Biogen Inc. logo

Biogen Inc.

NASDAQ:BIIB

Overview | Financials
Company Name Biogen Inc.
Symbol BIIB
Currency USD
Price 139.44
Market Cap 20,410,530,000
Dividend Yield 0%
52-week-range 128.51 - 238
Industry Drug Manufacturers—General
Sector Healthcare
CEO Mr. Christopher A. Viehbacher
Website https://www.biogen.com

An error occurred while fetching data.

About Biogen Inc.

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; ADUHELM for

Related Stocks

DexCom, Inc. logo

DexCom, Inc.

DXCM

70.69 USD

IDEXX Laboratories, Inc. logo

IDEXX Laboratories, Inc.

IDXX

415.3 USD

Royalty Pharma plc logo

Royalty Pharma plc

RPRX

32.77 USD

Seagen Inc. logo

Seagen Inc.

SGEN

228.74 USD

Walgreens Boots Alliance, Inc. logo

Walgreens Boots Alliance, Inc.

WBA

11.23 USD

Align Technology, Inc. logo

Align Technology, Inc.

ALGN

166.2 USD

Illumina, Inc. logo

Illumina, Inc.

ILMN

85.6 USD

Financials

Numbers are in millions USD

Numbers are in millions USD